| General complications development | Respiratory complications development | ||||
---|---|---|---|---|---|---|
Yes (86) | No (1303) | Pa | Yes (43) | No (1346) | Pa | |
ASA score > 1 (No. (%)) | 20 (23.3) | 158 (12.1) | 0.003 | 12 (27.9) | 166 (12.3) | 0.003 |
Age Median [IQR], months | 54 [36–96] | 48 [27–84] | 0.050 | 60 [36–96] | 48 [27–84] | 0.071 |
Weight Median [IQR]), kg | 18.6 [12.5–27.0] | 16.6 [12.0–24.0] | 0.170 | 18.9 [12.0–24.0] | 17.0 [12.0–24.2] | 0.356 |
Male sex No. (%) | 62 (72.1) | 784 (60.2) | 0.028 | 32 (74.4) | 814 (60.5) | 0.065 |
Neuromuscolar diseases No. (%) | 5 (5.8) | 52 (4.0) | 0.409 | 5 (11.6) | 52 (3.9) | 0.028 |
Premedication No. (%) | 1063 (81.6) | 71 (82.6) | 0.821 | 34 (79.1) | 1100 (81.7) | 0.658 |
Multipharmacological anaesthesia No. (%) | 7 (8.1) | 39 (3.0) | 0.010 | 0 (0.0) | 46 (3.4) | 0.218 |
Anaesthesia length > 50 min No. (%) | 67 (77.9) | 875 (67.2) | 0.039 | 35 (81.4) | 907 (67.4) | 0.053 |
Season autumn-winter No. (%) | 47 (54.7) | 633 (48.6) | 0.276 | 28 (65.1) | 652 (48.4) | 0.031 |